Paul L Weiden

age ~82

from Sun City West, AZ

Get Report

Also known as:

Paul Lincoln Weiden
Paul Living Weiden
Paul L Welden
Paul L Wieden
Paul L Weinden
Weiden Weiden

Phone and address:: 14134 W Pecos Ln, Sun City, AZ 85375

Connected to:

Paul Weiden Phones & Addresses

14134 W Pecos Ln, Sun City West, AZ 85375
Sammamish, WA
2028 Fairview Ave E APT 2026, Seattle, WA 98102 • 2065686149
2026 Fairview Ave, Seattle, WA 98121
2028 Fairview Ave E, Seattle, WA 98102
Menlo Park, CA
Kirkland, WA
Bellevue, WA
Mountain View, CA
Sunnyvale, CA
Mercer Island, WA
Bothell, WA
2028 Fairview Ave E, Seattle, WA 98102 • 2065686149

Work

Position:

Medical Professional

Education

Degree:

Graduate or professional degree

Medicine Doctors

Paul L. Weiden

view source

Specialties:

Hematology/Oncology

Work:

Bartlett Surgery & Specialty Clinic
3225 Hospital Dr UNIT 101A, Juneau, AK 99801
9077968700 (phone), 9077968710 (fax)

Education:

Medical School
Harvard Medical School
Graduated: 1967

Procedures:

Bone Marrow Biopsy
Chemotherapy

Conditions:

Malignant Neoplasm of Female Breast

Languages:

English
Spanish

Description:

Dr. Weiden graduated from the Harvard Medical School in 1967. He works in Juneau, AK and specializes in Hematology/Oncology. Dr. Weiden is affiliated with Bartlett Regional Hospital.

Paul Weiden, Juneau AK

view source

Specialties:

Internal Medicine
Medical Oncology
Hematology & Oncology
Public Health & General Preventive Medicine

Work:

Bartlett Surgery & Specialty Clinic
3225 Hospital Dr, Juneau, AK 99801
Seattle Cancer Care Alliance
1959 NE Pacific St, Seattle, WA 98195
Harborview Medical Center
325 9Th Ave, Seattle, WA 98104
Seattle Cancer Care Alliance
825 Eastlake Ave E, Seattle, WA 98109

Education:

Harvard University(1967)

Name / Title

Company / Classification

Phones & Addresses

Paul L. Weiden
Medical Doctor, Principal

Weiden Family Investments LLC
Investor

2028 Fairview Ave E, Seattle, WA 98102

Paul Lincoln Weiden

Weiden Family California LLC
Investment Real Estate

2504 Yale Ave E, Seattle, WA 98102

Paul L. Weiden

Weiden Family California Property LLC
Real Property

2028 Fairview Ave E, Seattle, WA 98102
251 Bartlett St, San Francisco, CA 94110

Us Patents

Use Of Picoplatin To Treat Colorectal Cancer
view source
US Patent:

8173686, May 8, 2012
Filed:

May 13, 2009
Appl. No.:

12/465563
Inventors:

David A. Karlin - Los Altos CA, US
Hazel B. Breitz - Seattle WA, US
Paul L. Weiden - Seattle WA, US
Assignee:

Poniard Pharmaceuticals, Inc. - Seattle WA
International Classification:

A61K 31/44
US Classification:

514357
Abstract:

The invention provides a method of treatment of colorectal cancer by administration of the anti-cancer platinum drug picoplatin in conjunction with 5-FU and leucovorin in a variety of treatment regimens.

Use Of Picoplatin To Treat Colorectal Cancer
view source
US Patent:

8178564, May 15, 2012
Filed:

Feb 6, 2009
Appl. No.:

12/367394
Inventors:

David A. Karlin - Los Altos CA, US
Hazel B. Breitz - Seattle WA, US
Paul L. Weiden - Seattle WA, US
Assignee:

Poniard Pharmaceuticals, Inc. - Seattle WA
International Classification:

A61K 31/44
US Classification:

514357
Abstract:

The invention provides a method of treatment of colorectal cancer by administration of the anti-cancer platinum drug picoplatin in conjunction with 5-FU and leucovorin in a variety of treatment regimens. Dosages, dosing schedules, and ancillary treatments are described.

Use Of Picoplatin To Treat Colorectal Cancer
view source
US Patent:

20090275549, Nov 5, 2009
Filed:

May 12, 2009
Appl. No.:

12/464662
Inventors:

David A. Karlin - Los Altos CA, US
Hazel B. Breitz - Seattle WA, US
Paul L. Weiden - Seattle WA, US
Assignee:

Poniard Pharmaceuticals, Inc. - Seattle WA
International Classification:

A61K 31/282
A61P 35/00
US Classification:

514188
Abstract:

The invention provides a method of treatment of colorectal cancer by administration of the anti-cancer platinum drug picoplatin in conjunction with 5-FU and leucovorin in a variety of treatment regimens.

Combination Therapy For Ovarian Cancer
view source
US Patent:

20100178328, Jul 15, 2010
Filed:

Dec 10, 2009
Appl. No.:

12/635534
Inventors:

Ronald A. Martell - San Francisco CA, US
David A. Karlin - Los Altos CA, US
Hazel B. Breitz - Seattle WA, US
Paul L. Weiden - Seattle WA, US
Assignee:

Poniard Pharmaceuticals, Inc. - Seattle WA
International Classification:

A61K 9/127
A61P 35/00
A61K 31/704
A61P 17/00
US Classification:

424450, 514 34
Abstract:

The present invention provides a method to treat ovarian cancer by the administration of effective amounts of picoplatin and pegylated liposomal doxorubicin.

Stabilized Picoplatin Dosage Form
view source
US Patent:

20100215727, Aug 26, 2010
Filed:

Dec 10, 2009
Appl. No.:

12/635517
Inventors:

Alistair J. Leigh - Seattle WA, US
Ronald A. Martell - San Francisco CA, US
David A. Karlin - Los Altos CA, US
Cheni Kwok - San Mateo CA, US
Christopher A. Procyshyn - Surrey, CA
Hazel B. Breitz - Seattle WA, US
Paul L. Weiden - Seattle WA, US
Assignee:

Poniard Pharmaceuticals, Inc. - Seattle WA
International Classification:

A61K 9/127
A61K 31/555
A61K 39/395
A61K 31/7068
A61P 35/00
A61P 35/02
US Classification:

424450, 514188, 4241331, 514 49
Abstract:

Methods for stabilizing aqueous solutions of picoplatin are provided. Such stable, preferably aseptic solutions are particularly useful for preparing unit dosages of picoplatin for oral or intravenous administration, preferably in combination with at least one additional non-platinum anti-cancer agent.

Use Of Picoplatin To Treat Prostate Cancer
view source
US Patent:

20120122825, May 17, 2012
Filed:

May 12, 2010
Appl. No.:

13/319647
Inventors:

David A. Karlin MD - Los Altos CA, US
Hazel B. Breitz MD - Seattle WA, US
Paul L. Weiden MD - Seattle WA, US
Robert De Jager - Rancho Santa Fe CA, US
Assignee:

Poniard Pharmaceuticals, Inc. - Seattle WA
International Classification:

A61K 31/555
A61P 25/00
A61P 35/00
A61K 31/573
A61P 29/00
US Classification:

514171, 514188
Abstract:

The invention provides a method of treatment of metastatic hormone-refractory prostate cancer involving substantially as concurrent administration of picoplatin and docetaxel. Prednisone may also be administered. Dosages and dosing regimens are provided.

Use Of Picoplatin To Treat Colorectal Cancer
view source
US Patent:

20120156199, Jun 21, 2012
Filed:

May 12, 2010
Appl. No.:

13/319852
Inventors:

David A. Karlin - Los Altos CA, US
Hazel B. Breitz - Seattle WA, US
Paul L. Weiden - Seattle WA, US
Assignee:

Poniard Pharmaceuticals, Inc. - Seattle WA
International Classification:

A61K 39/395
A61P 35/04
A61P 35/00
US Classification:

4241331
Abstract:

The invention provides a method of treatment of colorectal cancer by administration of the anti-cancer platinum drug picoplatin in conjunction with 5-FU and leucovorin in a variety of treatment regimens.

Method To Treat Small Cell Lung Cancer
view source
US Patent:

20130203725, Aug 8, 2013
Filed:

Mar 4, 2011
Appl. No.:

13/582922
Inventors:

Hazel B. Breitz - Seattle WA, US
Robert De Jager - Rancho Santa Fe CA, US
Paul L. Weiden - Seattle WA, US
Assignee:

Poniard Pharmaceuticals, Inc. - Seattle WA
International Classification:

A61K 31/555
A61K 45/06
US Classification:

514188
Abstract:

A method for treatment of small cell lung cancer (SCLC) that does not respond to first-line treatment or that progresses following cessation of first-line organoplatinum chemotherapy is provided that includes the administration of picoplatin, optionally in conjunction with a regimen of best supportive care. Multiple doses of picoplatin can be administered. The picoplatin can also treat SCLC that has metastacized to the brain.